Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 272

1.

Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea.

Fant RV, Henningfield JE, Cash BD, Dove LS, Covington PS.

Clin Gastroenterol Hepatol. 2017 Feb 3. pii: S1542-3565(17)30134-9. doi: 10.1016/j.cgh.2017.01.026. [Epub ahead of print]

PMID:
28167156
2.

Response to Kolodny: Negative Outcomes of Unbalanced Opioid Policy Supported by Clinicians, Politicians, and the Media.

Scholten W, Henningfield JE.

J Pain Palliat Care Pharmacother. 2016 Dec;30(4):332-334. No abstract available.

PMID:
27841693
3.

Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Henningfield JE, Smith TT, Kleykamp BA, Fant RV, Donny EC.

Psychopharmacology (Berl). 2016 Dec;233(23-24):3829-3848. Review.

PMID:
27766371
4.

Negative outcomes of unbalanced opioid policy supported by clinicians, politicians, and the media.

Scholten W, Henningfield JE.

J Pain Palliat Care Pharmacother. 2016;30(1):4-12. doi: 10.3109/15360288.2015.1136368.

PMID:
26890500
5.

Providing a Science Base for the Evaluation of Tobacco Products.

Berman ML, Connolly G, Cummings KM, Djordjevic MV, Hatsukami DK, Henningfield JE, Myers M, O'Connor RJ, Parascandola M, Rees V, Rice JM, Shields PG.

Tob Regul Sci. 2015 Apr;1(1):76-93.

6.

Pain management strategies and lessons from the military: A narrative review.

Vallerand AH, Cosler P, Henningfield JE, Galassini P.

Pain Res Manag. 2015 Sep-Oct;20(5):261-8. Review.

7.

The unique role of transdermal buprenorphine in the global chronic pain epidemic.

Pergolizzi JV Jr, Scholten W, Smith KJ, Leighton-Scott J, Willis JC, Henningfield JE.

Acta Anaesthesiol Taiwan. 2015 Jun;53(2):71-6. doi: 10.1016/j.aat.2015.06.001.

8.

A meta-analysis based on diffuse definitions and mixed quality literature is not a good fundament for decisions on treatment of chronic pain patients.

Scholten W, Henningfield JE.

Pain. 2015 Aug;156(8):1576-7. doi: 10.1097/j.pain.0000000000000213. No abstract available.

PMID:
26176808
9.

A literature review on prevalence of gender differences and intersections with other vulnerabilities to tobacco use in the United States, 2004-2014.

Higgins ST, Kurti AN, Redner R, White TJ, Gaalema DE, Roberts ME, Doogan NJ, Tidey JW, Miller ME, Stanton CA, Henningfield JE, Atwood GS.

Prev Med. 2015 Nov;80:89-100. doi: 10.1016/j.ypmed.2015.06.009. Review.

10.

Concluding statement - neuropharmacological basis and clinical rationale for control of transdermal buprenorphine as a step II analgesic.

Henningfield JE, Sun WZ.

Acta Anaesthesiol Taiwan. 2015 Jun;53(2):77-9. doi: 10.1016/j.aat.2015.05.002.

11.

Agonist Medications for the Treatment of Cocaine Use Disorder.

Negus SS, Henningfield J.

Neuropsychopharmacology. 2015 Jul;40(8):1815-25. doi: 10.1038/npp.2014.322. Review. No abstract available.

12.

NIH electronic cigarette workshop: developing a research agenda.

Walton KM, Abrams DB, Bailey WC, Clark D, Connolly GN, Djordjevic MV, Eissenberg TE, Fiore MC, Goniewicz ML, Haverkos L, Hecht SS, Henningfield JE, Hughes JR, Oncken CA, Postow L, Rose JE, Wanke KL, Yang L, Hatsukami DK.

Nicotine Tob Res. 2015 Feb;17(2):259-69. doi: 10.1093/ntr/ntu214.

13.

CNS stimulants.

Heal DJ, Smith SL, Henningfield JE.

Neuropharmacology. 2014 Dec;87:1-3. doi: 10.1016/j.neuropharm.2014.09.025. No abstract available.

PMID:
25278034
14.

The tobacco endgame: it's all about behavior.

Henningfield JE.

Prev Med. 2014 Nov;68:11-6. doi: 10.1016/j.ypmed.2014.09.003.

PMID:
25236479
15.

William L. Woolverton: a case history in unraveling the behavioral pharmacology of stimulants.

Nader MA, Balster RL, Henningfield JE.

Neuropharmacology. 2014 Dec;87:4-8. doi: 10.1016/j.neuropharm.2014.05.004. Review.

16.

Epidemiology of stimulant misuse and abuse: implications for future epidemiologic and neuropharmacologic research.

Gerlach KK, Dasgupta N, Schnoll SH, Henningfield JE.

Neuropharmacology. 2014 Dec;87:91-6. doi: 10.1016/j.neuropharm.2014.04.020. Review.

PMID:
24813641
17.

Reducing the nicotine content to make cigarettes less addictive.

Benowitz NL, Henningfield JE.

Tob Control. 2013 May;22 Suppl 1:i14-7. doi: 10.1136/tobaccocontrol-2012-050860. Review.

18.

Nicotine reduction: strategic research plan.

Hatsukami DK, Benowitz NL, Donny E, Henningfield J, Zeller M.

Nicotine Tob Res. 2013 Jun;15(6):1003-13. doi: 10.1093/ntr/nts214. Review.

19.

Transitions to regular smoking and nicotine dependence in the Adolescent National Comorbidity Survey (NCS-A).

Dierker L, Swendsen J, Rose J, He J, Merikangas K; Tobacco Etiology Research Network (TERN)..

Ann Behav Med. 2012 Jun;43(3):394-401. doi: 10.1007/s12160-011-9330-9.

PMID:
22160800
20.

Tobacco psychopharmacology and public health policy: it takes a community.

Henningfield JE.

Exp Clin Psychopharmacol. 2011 Aug;19(4):249-62. doi: 10.1037/a0024316. Review.

PMID:
21728446
Items per page

Supplemental Content

Loading ...
Support Center